Tenosynovitis

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023

Retrieved on: 
Tuesday, May 30, 2023

THOUSAND OAKS, Calif., May 30, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new research examining the use of Otezla® (apremilast) in psoriatic arthritis, including the Phase 4 MOSAIC study and an exploratory analysis of cardiometabolic risk factors, which are commonly elevated in patients with psoriatic disease. The findings will be presented at the 2023 European Congress of Rheumatology (EULAR), taking place May 31-June 3 in Milan, Italy.

Key Points: 
  • The findings will be presented at the 2023 European Congress of Rheumatology (EULAR), taking place May 31-June 3 in Milan, Italy.
  • "Research presented at EULAR sheds new light on psoriatic arthritis and the role of our oral medication Otezla," said Ponda Motsepe-Ditshego, vice president, Global Medical at Amgen.
  • MOSAIC evaluated Otezla's effect on joint inflammation and structural progression of psoriatic arthritis measured by MRI.
  • "The results of this study are encouraging, as they provide important insights about Otezla treatment and its efficacy on both clinical and inflammatory manifestations of psoriatic arthritis."

Joint Pain Injections Global Market Report 2022: Significant Rise in Tenosynovitis and Prolonged Physical Activity Fuels Demand - ResearchAndMarkets.com

Retrieved on: 
Monday, January 30, 2023

Hyaluronic acid injection is reigning the injections segment for joint pain injections market.

Key Points: 
  • Hyaluronic acid injection is reigning the injections segment for joint pain injections market.
  • Currently knee & ankle joints are dominating the joint segment for joint pain injections market.
  • The major factors associated with its market growth are significant rise in tenosynovitis and prolonged physical activity.
  • North America with a share of 34% is leading the regional segment for joint pain injections market.

Get a Grip? It's All About Pain for Thumb Tendonitis Patients

Retrieved on: 
Thursday, January 16, 2020

De Quervain's tenosynovitis is characterized by inflammation and swelling of two main tendons that pass through a narrow tunnel located on the thumb side of the wrist and control thumb movement, explains Dr. Badia.

Key Points: 
  • De Quervain's tenosynovitis is characterized by inflammation and swelling of two main tendons that pass through a narrow tunnel located on the thumb side of the wrist and control thumb movement, explains Dr. Badia.
  • He is a specialist in treating musculoskeletal disorders of the hands, wrists and other upper limbs.
  • The synovium is what enables the thumb tendons to glide readily through the tunnel.
  • Common symptoms of the disorder are pain and swelling at the base of the thumb or on the thumb side of the wrist, a sensation of "sticking" or "snapping" when moving the thumb and difficulty or pain, including pain that travels up the forearm, when attempting to grasp or "pinch" something forcefully.